Evidence map›Paper›PMID 28000701›Full record

ArticleEuropean journal of human genetics : EJHG2017

The diagnostic yield of whole-exome sequencing targeting a gene panel for hearing impairment in The Netherlands.

Celia Zazo Seco, Mieke Wesdorp, Ilse Feenstra, Rolph Pfundt, Jayne Y Hehir-Kwa, Stefan H Lelieveld, Steven Castelein, Christian Gilissen, Ilse J de Wijs, Ronald Jc Admiraal and 20 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Parental experience of whole genome sequencing for children with sensorineural hearing loss.International journal of qualitative studies on health and well-being · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Hearing Loss and Audiogenic Seizures Induced by Hypofunctional Prestin Variants.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  12. Cochlear Implantation Outcomes in Genotyped Subjects with Sensorineural Hearing Loss.Journal of the Association for Research in Otolaryngology : JARO · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Extreme Phenotypic Variability ofAdvanced genetics (Hoboken, N.J.) · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Mutational spectrum in patients with dominant non-syndromic hearing loss in Austria.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Celia Zazo SecoDepartment of Otorhinolaryngology, Hearing and Genes, Radboud University Medical Center, Nijmegen, The Netherlands.
Mieke WesdorpDepartment of Otorhinolaryngology, Hearing and Genes, Radboud University Medical Center, Nijmegen, The Netherlands.
Ilse FeenstraDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Rolph PfundtThe Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Jayne Y Hehir-KwaThe Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Stefan H LelieveldDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Steven CasteleinDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Christian GilissenDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-1693-9699
Ilse J de WijsDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Ronald Jc AdmiraalDepartment of Otorhinolaryngology, Hearing and Genes, Radboud University Medical Center, Nijmegen, The Netherlands.
Ronald Je PenningsDepartment of Otorhinolaryngology, Hearing and Genes, Radboud University Medical Center, Nijmegen, The Netherlands.
Henricus Pm KunstDepartment of Otorhinolaryngology, Hearing and Genes, Radboud University Medical Center, Nijmegen, The Netherlands.
Jiddeke M van de KampDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Saskia TammingaDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Arjan C HouwelingDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Astrid S PlompDepartment of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Saskia M MaasDepartment of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Pia Am de Koning GansDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Sarina G KantDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Christa M de GeusDepartment of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.
Suzanna Gm FrintsDepartment of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands.
Els K VanhoutteDepartment of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands.
Marieke F van DoorenDepartment of Clinical Genetics, Erasmus Medical Centre, Rotterdam, The Netherlands.
Marie-José H van den BoogaardDepartment of Clinical Genetics, Utrecht Medical Center/Wilhelmina Children's Hospital, Utrecht, The Netherlands.
Hans SchefferThe Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Marcel NelenDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Hannie KremerDepartment of Otorhinolaryngology, Hearing and Genes, Radboud University Medical Center, Nijmegen, The Netherlands.
Lies HoefslootDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Margit SchradersDepartment of Otorhinolaryngology, Hearing and Genes, Radboud University Medical Center, Nijmegen, The Netherlands.
Helger G YntemaThe Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hearing impairment (HI) is genetically heterogeneous which hampers genetic counseling and molecular diagnosis. Testing of several single HI-related genes is laborious and expensive. In this study, we evaluate the diagnostic utility of whole-exome sequencing (WES) targeting a panel of HI-related genes. Two hundred index patients, mostly of Dutch origin, with presumed hereditary HI underwent WES followed by targeted analysis of an HI gene panel of 120 genes. We found causative variants underlying the HI in 67 of 200 patients (33.5%). Eight of these patients have a large homozygous deletion involving STRC, OTOA or USH2A, which could only be identified by copy number variation detection. Variants of uncertain significance were found in 10 patients (5.0%). In the remaining 123 cases, no potentially causative variants were detected (61.5%). In our patient cohort, causative variants in GJB2, USH2A, MYO15A and STRC, and in MYO6 were the leading causes for autosomal recessive and dominant HI, respectively. Segregation analysis and functional analyses of variants of uncertain significance will probably further increase the diagnostic yield of WES.

Indexed as

ExomeConnexin 26ConnexinsDNA Copy Number VariationsExtracellular Matrix ProteinsGenetic TestingGPI-Linked ProteinsHearing LossHumansIntercellular Signaling Peptides and ProteinsMembrane ProteinsMutationMyosin Heavy ChainsMyosinsNetherlandsSequence Analysis, DNAConnexin 26ConnexinsExtracellular Matrix ProteinsGJB2 protein, humanGPI-Linked ProteinsIntercellular Signaling Peptides and ProteinsMembrane ProteinsMYO15A protein, humanMyosin Heavy ChainsMyosinsmyosin VIOTOA protein, humanSTRC protein, humanUSH2A protein, human

Identifiers

PMID28000701
PMCPMC5315517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.